Evidence map›Paper›PMID 19027147›Full record

ArticleThe Journal of allergy and clinical immunology2009

A novel group of rhinoviruses is associated with asthma hospitalizations.

E Kathryn Miller, Kathryn M Edwards, Geoffrey A Weinberg, Marika K Iwane, Marie R Griffin, Caroline B Hall, Yuwei Zhu, Peter G Szilagyi, Laura-Lee Morin, Luke H Heil and 3 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in The Journal of allergy and clinical immunology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 144 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
144citing papers in PubMed, 1 pooled it
17.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

144 citing papers in PubMed, 1 synthesis or guideline pooled it, 263 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Effects of montelukast on patients with asthma after experimental inoculation with human rhinovirus 16.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2011
    Trial
  4. High-dose vitamin DEClinicalMedicine · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Beyond respiratory syncytial virus and rhinovirus: The other viral respiratory bandits.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

84 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

E Kathryn MillerDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232-9500, USA. eva.k.miller@vanderbilt.edu
Kathryn M Edwards
Geoffrey A Weinberg
Marika K Iwane
Marie R Griffin
Caroline B Hall
Yuwei Zhu
Peter G Szilagyi
Laura-Lee Morin
Luke H Heil
Xiaoyan Lu
John V Williams
New Vaccine Surveillance Network
Vanderbilt University Medical Center · USUniversity of Rochester · USNational Center for Immunization and Respiratory Diseases · USCancer Research And Biostatistics · US

Funding

Enhanced Surveillance-Newly Vaccine Preventable DiseasesU01IP000017 · IP · UNIVERSITY OF ROCHESTER · PI SZILAGYI, PETER G · 2004 to 2010
$3.8M
Enhanced Surveillance: New Vaccine Preventable DiseasesU01IP000022 · IP · VANDERBILT UNIVERSITY · PI EDWARDS, KATHRYN MARGARET · 2004 to 2010
$3.6M
Vanderbilt Health Services Research Training ProgramT32HS013833 · AHRQ · VANDERBILT UNIVERSITY · PI GRIFFIN, MARIE R. · 2003 to 2012
$1.8M
AHRQ HHS T32 HS013833AHRQ HHS T32 HS 13833-02NCIRD CDC HHS U01 IP000017NCIRD CDC HHS U01/IP000017NCIRD CDC HHS U01 IP000022NCIRD CDC HHS U01/IP000022PHS HHS U38/CCU217969PHS HHS U38/CCU417958
6 · The paper itself

Abstract

backgroundAlthough recent studies have identified new group C human rhinoviruses (HRVCs), their spectrum of pediatric disease is unknown.

objectiveWe sought to determine the presentation and burden of disease caused by HRVCs among young hospitalized children.

methodsWe conducted prospective population-based surveillance in 2 US counties among children less than 5 years of age hospitalized with acute respiratory illness or fever from October 2001 through September 2003. Nasal/throat swabs were obtained and tested for HRVs, as determined by means of RT-PCR and then characterized by means of partial sequencing.

resultsOf 1052 children enrolled and tested during the 2-year period, 167 (16%) had HRVs detected. Of 147 samples successfully sequenced, 64 were group A HRVs, 6 were group B HRVs, and 77 were HRVCs. Children with HRVCs were significantly more likely than those with group A HRVs to have underlying high-risk conditions, such as asthma (42% vs 23%, P = .023) and to have had a discharge diagnosis of asthma (55% vs 36%, P = .022).

conclusionsOverall, HRVCs were detected in 7% of children hospitalized for fever or respiratory conditions and constituted almost half of all rhinovirus-associated hospitalizations, suggesting that this novel group causes a substantial burden of pediatric disease.

Indexed as

RhinovirusAcute DiseaseAsthmaChild, PreschoolCommunicable Diseases, EmergingFemaleFollow-Up StudiesHospitalizationHumansInfantMaleNew YorkPicornaviridae InfectionsProspective Studies

Identifiers

PMID19027147
PMCPMC7112283
OpenAlexW2041501280

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.